Using silkworms as a laboratory animal to evaluate medicines and foods.
- 1 January 2016
- journal article
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Drug Discoveries & Therapeutics
- Vol. 10 (1), 1-2
- https://doi.org/10.5582/ddt.2016.01018
Abstract
For this special issue, we, the Editors of Drug Discoveries & Therapeutics, have asked researchers who are using silkworms to actively develop drugs and study foods to summarize their recent work. Our profound hope is that this special issue encourages researchers who are helping to develop the new field of "using silkworms as a laboratory animal to evaluate medicines and foods".Keywords
This publication has 11 references indexed in Scilit:
- Lysocin E is a new antibiotic that targets menaquinone in the bacterial membraneNature Chemical Biology, 2014
- In vitro and in vivo anti-MRSA activities of nosokomycinsDrug Discoveries & Therapeutics, 2014
- An Invertebrate Hyperglycemic Model for the Identification of Anti-Diabetic DrugsPLOS ONE, 2011
- Purification of innate immunostimulant from green tea using a silkworm muscle contraction assayDrug Discoveries & Therapeutics, 2011
- The Silkworm-An Attractive BioResource Supplied by JapanExperimental Animals, 2010
- Activation of the Silkworm Cytokine by Bacterial and Fungal Cell Wall Components via a Reactive Oxygen Species-triggered MechanismPublished by Elsevier BV ,2008
- Antifungal Chemical Compounds Identified Using a C. elegans Pathogenicity AssayPLoS Pathogens, 2007
- THE GENETICS AND GENOMICS OF THE SILKWORM, BOMBYX MORIAnnual Review of Entomology, 2005
- Drosophila melanogaster as a model host for Staphylococcus aureus infectionMicrobiology, 2004
- Quantitative Evaluation of the Therapeutic Effects of Antibiotics Using Silkworms Infected with Human Pathogenic MicroorganismsAntimicrobial Agents and Chemotherapy, 2004